FdaApplication
ANDA 079003
Identifiers
- fda_app_no: ANDA079003
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2012-03-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | EQ 150MG BASE | TABLET;ORAL |
1 product